Click to read the article in full.
Mark Glatman’s Abstract Securities has announced that its associated company, Abstract (Mid-Tech) Limited, has obtained detailed planning consent for the second phase of development at South Cambridge Science Centre (SCSC), aimed at life sciences and biotechnology occupiers comprising a building of 44,650 sq ft.
SCSC is being developed on a brownfield site in Sawston, approximately 6 miles south of Cambridge City Centre and close to Babraham Research Park, Granta Park, and Unity Campus and an established cluster of South Cambridge life science, biotechnology, pharmaceutical and research occupiers. Addenbrooke’s Hospital and Cambridge Biomedical Campus are within a 10 minute drive by car.
Mark Glatman, Chief Executive of Abstract, said: “We are now within a few months from completion of our first phase of development
link source - Commercial News Media https://www.commercialnewsmedia.com/wp-content/uploads/2024/10/abstr1-696x475.jpg